Join to access to all OVN content. Join for Free
Master Communication Skills to Improve Business Relations
MSL communication skills Medical Affairs engagement KOL and HCP engagement digital tools in MSL communication trends in Medical Affairs

Master Communication Skills to Improve Business Relations


Share This Article


Summary

In this episode, MSL Talk hosts its first live broadcast with panelists Ruth Phillips, Michael Kahn, John Caskey, and Brian Bischel. The conversation centers on enhancing communication skills within MSL teams, tackling deficiencies, and engaging effectively with KOLs and HCPs. The panel discusses internal communication challenges, the misalignment of goals in Medical Affairs, and strategies to combat remote communication fatigue. They explore the impact of digital tools, including social media and AI, on MSL engagement. Audience polls provide insights into stakeholder challenges, and panelists offer solutions for unresponsive stakeholders. The episode concludes with future trends in MSL communication.

The MSL Talk Podcast and Momentum Events teamed up for a first ever LIVE broadcast at the Medical Affairs Xcellence Summit, Philadelphia, PA. The live panel discussion was moderated by MSL Talk Host Tom Caravela and the topic was "Master Communication Skills to Improve Business Relations, and MAXimize Internal and External Engagement". Panelists included Bryan Bishel, Ruth Phillips and Michael Kahn.

The panel discussed:

πŸ‘‰ Training practices, techniques and trends that have been effective in developing communication skills for cross functional influence
πŸ‘‰ What skills need to be developed better for new or even seasoned professionals
πŸ‘‰ How professionals can position themselves better when contacting KOLs, DOLs and HCPs in general, gain better insights and create lasting relationships
πŸ‘‰ How an IIT program helps to drastically improve KOL engagement
πŸ‘‰ What engagement will look like in the next 5 years and what new trends might emerge.

Click for Source
MSL communication skills, Medical Affairs engagement, KOL and HCP engagement, digital tools in MSL, communication trends in Medical Affairs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, GaΓ«lle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Article
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Partner Avatar iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Explore OVN